Status:
COMPLETED
MR Guided Laser Interstitial Thermal Therapy for the "Minimal Invasive" Treatment of Brain Metastasis and Primary Brain Tumors
Lead Sponsor:
BioTex, Inc.
Conditions:
Brain Neoplasms
Brain Tumor
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
The purpose of this study is to determine if the stereotactic, MR guided, laser interstitial thermal therapy treatment technique can be safety and efficiently used for human brain metastasis and prima...
Detailed Description
This new "minimally invasive" technique has been tested so far, with success, on animal brain tumor models and on human liver metastasis. The main purpose of this study is to determine if the stereot...
Eligibility Criteria
Inclusion
- Patients 18 years of age or older
- Patients with brain metastasis located in the brain hemispheres
- Patient with a brain metastasis smaller or equal to 4 cm in diameter
- Patient with primary brain tumor smaller or equal to 4 cm in diameter
- Patient previously treated with other therapeutic techniques ( radio-therapy, chemotherapy, immunotherapy) which have failed.
Exclusion
- Patients less than 18 years old,
- Patients presenting contra indication for MRI studies
- Patient for which the primary cancer is melanoma or kidney tumors
- Patients having a mean life duration longer than 3 months (due to the primary cancer)
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2008
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00392119
Start Date
October 1 2006
End Date
December 1 2008
Last Update
January 1 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Lariboisiere
Paris, France, 75475